FindTrial
Sign In

Radiation safety monitoring after 131-I treatment in patients with differentiated thyroid cancer

Radiation safety monitoring after 131-I treatment in patients with differentiated thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069546
Enrollment
Unknown
Registered
2023-03-20
Start date
2023-03-20
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

131 Iodine treated patients:No

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: (1) total / subtotal thyroidectomy, confirmed by pathology as DTC (PTC, FTC); (2) complete clinical and pathological data; (3) regular follow-up.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Dose rate;—

Countries

China

Contacts

Public ContactPang Hua

The First Affiliated Hospital of Chongqing Medical University

ph1973@163.com15923039337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026